IDEAYA Biosciences Inc
NASDAQ:IDYA
IDEAYA Biosciences Inc
NASDAQ:IDYA
Price:
38.175 USD
0.43%
Market Closed
Updated:
Jun 10, 2024
IDEAYA Biosciences Inc
Net Issuance of Common Stock
|
IDEAYA Biosciences Inc
Net Issuance of Common Stock Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
IDEAYA Biosciences Inc
NASDAQ:IDYA
|
Net Issuance of Common Stock
$708.9m
|
CAGR 3-Years
68%
|
CAGR 5-Years
649%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Common Stock
-$1.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
37%
|
CAGR 10-Years
-18%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Common Stock
-$719m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
-2%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Common Stock
-$288.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Common Stock
-$473.2m
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is IDEAYA Biosciences Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
708.9m
USD
708.9m
USD
Based on the financial report for Mar 31, 2024, IDEAYA Biosciences Inc's Net Issuance of Common Stock amounts to 708.9m USD.
What is IDEAYA Biosciences Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
649%
649%
Over the last year, the Net Issuance of Common Stock growth was 613%. The average annual Net Issuance of Common Stock growth rates for IDEAYA Biosciences Inc have been 68% over the past three years , 649% over the past five years .
You don't have any saved screeners yet
